Fenclozic Acid

Summary

Fenclozic Acid (CHEMBL1909282) is an approved small molecule.

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• Chemistry: 253.71 Da · C11H8ClNO2S

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL1909282
Name	Fenclozic Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	28858
Molecular formula	C11H8ClNO2S
Molecular weight	253.71
InChIKey	APBSKHYXXKHJFK-UHFFFAOYSA-N

SMILES: C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl

IUPAC name: 2-[2-(4-chlorophenyl)-1,3-thiazol-4-yl]acetic acid

Also known as: Acide fenclozique, Acido fenclozico, Fenclozic acid, I.C.I. 54,450, ICI-54450, fenclozic acid, SID29216130, SID170466565, SID144205372, FENCLOZIC ACID, Fenclozic Acid

Patent coverage: 1,540 distinct patent families (6,552 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).